Hypocretin (orexin): role in normal behavior and neuropathology.
The hypocretins (Hcrts, also known as orexins) are two peptides, both synthesized by a small group of neurons, most of which are in the lateral hypothalamic and perifornical regions of the hypothalamus. The hypothalamic Hcrt system directly and strongly innervates and potently excites noradrenergic, dopaminergic, serotonergic, histaminergic, and cholinergic neurons. Hcrt also has a major role in modulating the release of glutamate and other amino acid transmitters. Behavioral investigations have revealed that Hcrt is released at high levels in active waking and rapid eye movement (REM) sleep and at minimal levels in non-REM sleep. Hcrt release in waking is increased markedly during periods of increased motor activity relative to levels in quiet, alert waking. Evidence for a role for Hcrt in food intake regulation is inconsistent. I hypothesize that Hcrt's major role is to facilitate motor activity tonically and phasically in association with motivated behaviors and to coordinate this facilitation with the activation of attentional and sensory systems. Degeneration of Hcrt neurons or genetic mutations that prevent the normal synthesis of Hcrt or of its receptors causes human and animal narcolepsy. Narcolepsy is characterized by an impaired ability to maintain alertness for long periods and by sudden losses of muscle tone (cataplexy). Administration of Hcrt can reverse symptoms of narcolepsy in animals, may be effective in treating human narcolepsy, and may affect a broad range of motivated behaviors.
Siegel
Jerome M
JM
Veterans Affairs Greater Los Angeles Healthcare System-Sepulveda, and Department of Psychiatry and Biobehavioral Sciences, Center for Sleep Research, University of California, Los Angeles, California 91343, USA. jsiegel@ucla.edu
D000818:Animals; D001143:Arousal / Q000502:physiology; D002352:Carrier Proteins / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D004302:Dorsomedial Hypothalamic Nucleus / Q000378:metabolism; D004399:Dynorphins / Q000032:analysis; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D009042:Motivation; D009290:Narcolepsy / Q000378:metabolism* / Q000503:physiopathology*; D009479:Neuropeptides / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D000068797:Orexins; D051381:Rats; D012895:Sleep, REM / Q000502:physiology*; D013569:Synapses / Q000378:metabolism
D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins; D004399:Dynorphins